Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective study.

Jeffrey, Angus W; Picardo, Sherman; Menon, Shankar; So, Kenji; Venugopal, Kannan

Jeffrey, Angus W; Picardo, Sherman; Menon, Shankar; So, Kenji; Venugopal, Kannan.

Afiliação

Jeffrey AW; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia.
Picardo S; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia.
Menon S; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia.
So K; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia.
Venugopal K; Department of Gastroenterology, Royal Perth Hospital, Perth, Australia.

Ann Gastroenterol ; 36(4): 430-436, 2023.

Article em En | MEDLINE | ID: mdl-37396006

Palavras-chave

Crohn's disease; Ulcerative colitis; biologics; thiopurines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Gastroenterol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google